4.4 Editorial Material

Key Points to Consider When Evaluating Andexxa for Formulary Addition

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

S. J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Letter Hematology

Andexanet alfa-The first 150 days

Sarah E. Culbreth et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Review Hematology

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

Adam Cuker et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Article Cardiac & Cardiovascular Systems

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

Gordon F. Tomaselli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Critical Care Medicine

Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

Jennifer A. Frontera et al.

NEUROCRITICAL CARE (2016)

Editorial Material Critical Care Medicine

Ten things you should consider before you believe a clinical practice guideline

R. Jaeschke et al.

INTENSIVE CARE MEDICINE (2015)

Review Critical Care Medicine

Clinical Trial Design in the Neurocritical Care Unit

C. E. Hall et al.

NEUROCRITICAL CARE (2012)

Article Medicine, General & Internal

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

Stephan A. Mayer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Kathy Miller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)